1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Bone Morphogenetic Protein (BMP) Receptor Activators -Pipeline Insights, 2016


DelveInsight’s, “Bone Morphogenetic Protein (BMP) Receptor Activators-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Bone Morphogenetic Protein (BMP) Receptor Activators. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Bone Morphogenetic Protein (BMP) Receptor Activators. DelveInsight’s Report also assesses the Bone Morphogenetic Protein (BMP) Receptor Activators therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitive pipeline landscape of Bone Morphogenetic Protein (BMP) Receptor Activators
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Bone Morphogenetic Protein (BMP) Receptor Activators pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Bone Morphogenetic Protein (BMP) Receptor Activators and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Bone Morphogenetic Protein (BMP) Receptor Activators -Pipeline Insights, 2016

- Bone Morphogenetic Protein (BMP) Receptor Activators Overview
- Bone Morphogenetic Protein (BMP) Receptor Activators Disease Associated
- Bone Morphogenetic Protein (BMP) Receptor Activators Pipeline Therapeutics
- Bone Morphogenetic Protein (BMP) Receptor Activators Therapeutics under Development by Companies
- Bone Morphogenetic Protein (BMP) Receptor Activators Filed and Phase III Products
- Comparative Analysis
- Bone Morphogenetic Protein (BMP) Receptor Activators Phase II Products
- Comparative Analysis
- Bone Morphogenetic Protein (BMP) Receptor Activators Phase I and IND Filed Products
- Comparative Analysis
- Bone Morphogenetic Protein (BMP) Receptor Activators Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Bone Morphogenetic Protein (BMP) Receptor Activators - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Bone Morphogenetic Protein (BMP) Receptor Activators - Discontinued Products
- Bone Morphogenetic Protein (BMP) Receptor Activators - Dormant Products
- Companies Involved in Therapeutics Development for Bone Morphogenetic Protein (BMP) Receptor Activators
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Bone Morphogenetic Protein (BMP) Receptor Activators by Therapy Area, 2016
- Number of Products under Development for Bone Morphogenetic Protein (BMP) Receptor Activators, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Monotherapy Products
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Combination Products
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Route of Administration
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Stage and Route of Administration
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Molecule Type
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Stage and Molecule Type
- Bone Morphogenetic Protein (BMP) Receptor Activators Therapeutics - Discontinued Products
- Bone Morphogenetic Protein (BMP) Receptor Activators Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Bone Morphogenetic Protein (BMP) Receptor Activators by Therapy Area, 2016
- Number of Products under Development for Bone Morphogenetic Protein (BMP) Receptor Activators, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Monotherapy Products
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Combination Products
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Route of Administration
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Stage and Route of Administration
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Molecule Type
- Bone Morphogenetic Protein (BMP) Receptor Activators Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global protein labeling market is expected to reach USD 1,894.5 million by 2020 from USD 1,089.5 million in 2015, at a CAGR of 11.7% from 2015 to 2020. On the basis of products, the protein labeling ...

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...


Download Unlimited Documents from Trusted Public Sources

Protein Industry in the US

  • December 2016
    18 pages
  • Protein  

  • United States  

View report >

Influenza Statistics in the US

  • November 2016
    7 pages
  • Influenza  

    Influenza Vacci...  

    Vaccine  

  • United States  

View report >

The future of the Protein Industry in the Netherlands

  • November 2016
    8 pages
  • Protein  

    Food  

  • Netherlands  

View report >

Related Market Segments :

Protein

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.